High-risk meds and safety

Patient safety in regard to high-risk medicines is a new focus for two organisations who have joined together to help Australian clinical pharmacists have an unprecedented opportunity to improve patient safety in the use of high-risk medicines through a new $30,000 Juno Pharmaceuticals research grant, the SHPA says. The grant has almost doubled the pool